60 filings
Page 2 of 3
8-K
nkppkmrkv9
17 Feb 23
Other Events
4:13pm
8-K
qnkdrwp21218t5ns6p
13 Feb 23
Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering
5:30pm
8-K
tty11r dl4ln
31 Jan 23
Results of Special Meeting of Stockholders
5:09pm
8-K
bepdcla
10 Jan 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / January 2023 www.revbiosciences.com
4:07pm
8-K
s2et4bcoz xu
10 Jan 23
Revelation Biosciences Inc. Announces Pricing of Upcoming Automatic Unit Separation
4:02pm
8-K
md8m8 9sr
21 Dec 22
Entry into a Material Definitive Agreement
4:11pm
8-K
kayk9pnzz4afp21q
12 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
pjkknl 51
25 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:11am
8-K
i2guijdxf
10 Nov 22
Results of Operations and Financial Condition
5:00pm
8-K
trubd2
25 Oct 22
Revelation Biosciences Inc. Announces Positive Results in Preclinical Model
4:01pm
8-K
zup s6i55ig0t
6 Oct 22
Developing innovative therapeutics to address unmet needs Corporate Presentation / October 2022 www.revbiosciences.com
4:02pm
8-K
c5oeqn5
17 Aug 22
Results of Operations and Financial Condition
4:32pm
8-K
jgdmy h0l
1 Aug 22
Revelation Biosciences Inc. Announces Pricing of $5 Million Public Offering
5:09pm
8-K
5qovcn4q54ow0rj
10 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:00pm
8-K
0149 1r6v12jkrbl0n
31 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:46pm
8-K
f0nvcs3r
16 May 22
Results of Operations and Financial Condition
6:34pm
8-K
y9hryx 6h
6 May 22
Changes in Registrant's Certifying Accountant
4:05pm
8-K/A
0nmdyq 8tsw66xt
22 Apr 22
Index to Financial Statements
5:21pm
8-K/A
y8es sxukscnez
15 Apr 22
Index to Financial Statements
5:27pm
8-K
pvk 8vaq766sgle
15 Mar 22
Developing innovative therapeutics and diagnostics to address unmet needs Corporate Presentation / March 2022 www.revbiosciences.com
3:09pm